Helpline 07939 046 030
Freephone 0300 102 17 22*

Celebrating World NF Day: The Importance of Our Services

17 May 2026

The Importance of World NF Day
and World NF Awareness Month May

Every May, the NF Community comes together to recognise World NF Awareness Month, a time dedicated to raising awareness, support and hope. NF is classified as a rare neuro-genetic condition and impacts millions of people worldwide, making awareness and education of the condition critically important.

Understanding Neurofibromatosis

Neurofibromatosis is a group of genetic conditions that cause tumours to grow on nerves throughout the body. These tumours are usually non-cancerous, but they can lead to serious complications including hearing loss, vision problems, bone deformities, learning disabilities, chronic pain amongst many other conditions. Because symptoms vary greatly from person to person, many individuals face delayed diagnosis and misunderstanding about their condition.

Our Services

Nerve Tumours UK funds a Unique Specialist Support Network to help the 26,500+ people living in the UK who are diagnosed with NF (NF1, NF2 & SWN), along with their carers, families and wider support network, including the many medical professionals and other allied healthcare professionals who support those with the condition.

We provide support, advice and information via our Specialist Support Network, which comprises regionally-based nurses, a national helpline, fully accessible website, social media support groups, clinical guidelines, regional information days, medical guidelines and leaflets.

The Importance of Our Services.
Reflections By Our Community

Georgia Baum, Youth Ambassador and Equal Rights Campaigner who has NF1

This month is not only about awareness, but about recognising the importance of support, representation, and community. NF is not a ‘one sized fits all’ condition, each person will have a different experience.

Read Georgia's Blog

Emily Owen, Author, Speaker, Rare Disease Campaigner and Ambassador of Nerve Tumours UK who has NF2-SWN

As an author, I love the beauty of a well-structured sentence. As a patient, I value, immensely, those who structure the treatment part of my life sentence. Their care, and expertise, and compassion, and time, is reassuring and steadying.

Read Emily Owen's blog

Oliver, who has NF1, attended the NTUK 2026 Milton Keynes NF1 Medical Information Day

What stayed with me long after the day ended wasn’t the venue, the schedule, or even the information shared. It was the people. The very brave people. The patients, the care givers, the advocates. All of us, together, seeking answers.

Read Oliver's May blog

Safiya, who has NF1, reflects on our Specialist NF Nurses & Advisors

One of the challenges has been that not all medical professionals are familiar with NF1. That being said, the support I’ve received from the Nerve Tumours UK community and specialist teams has been incredibly reassuring, and it has made such a difference.

Read her story

Genn, who has NF1

I underwent a major surgery to debulk my plexiform tumour and I am still recovering. I’m grateful for organisations like NTUK who advocate for NF awareness and I feel hopeful that more studies can be done so our voices are further heard.

Read her story

Beth, who has NF1, is a Rare Disease Advocate and NF Social Community Blogger

May is NF Awareness Month, so I am doing an NF fact a day. I have NF1 so I am raising as much awareness as I can!

Follow her blog, including her daily facts throughout May

Briony and Kai, who has NF1, reflect on their regional Specialist NF Nurse.

Clare really goes out of her way to help us, not just individually but as a family as well. She signposts us to different places for support and is always there, even if it’s just for a quick email update about Kai.

Read their story

Reece & brother Carl have NF2, as did their dad & grandfather

We have the support of Nerve Tumours UK and other charities, ongoing research every day, and the people around us, like Charlotte, committing to doing her inspirational “50K in May” to raise awareness.

Read their story

Anne mother of a daughter with NF1 May 2026

My daughter died when she was 4 (she would now be 28 so it was a long time ago) and had very extreme NF1. Her doctor was a paediatrician but not a NF1 specialist.  I wish I had had your charity on my doorstep then!

 

Jodi mother of a daughter with NF1 May 2026

My daughter was born five weeks early on 29 August 2018, and from the very beginning she was our perfect little addition — a tiny, beautiful baby who brought so much love into our lives.

At just seven weeks old, she began to struggle with feeding, and we were admitted to Sheffield Children’s Hospital. It was there that a paediatric doctor, whose care and attentiveness changed everything for us, noticed marks on her skin and gently introduced us to a condition we had never heard of before — Neurofibromatosis. After genetic testing, that possibility became our reality.

What followed was a whirlwind of appointments and difficult news. Rosie was diagnosed with an optic glioma, glaucoma in her left eye, and additional tumours affecting her tongue, throat, and neck. As a parent, it was overwhelming, frightening, and at times incredibly difficult to process.

We were referred to the specialists at Ryegate Children’s Centre, where we met Clare Dhillon, specialists, and the wider neurodisability team. From that moment on, we were no longer facing this journey alone.

The care we have received at Ryegate has been nothing short of extraordinary. Not only have they supported Rosie medically, but they have also supported me emotionally through some of the hardest moments of my life. They take the time to truly understand Rosie — not just her condition, but who she is as a little girl — and they treat us both with kindness, patience, and respect.

There have been times when I have struggled to come to terms with Rosie’s diagnosis, but the team have never made me feel alone. They consistently go above and beyond, always ensuring that I feel informed, listened to, and reassured. Their compassion has helped ease so much of the worry that comes with a diagnosis like this.

Because of them, my child is not just receiving care — she is being cared for in the fullest sense of the word.

To Clare, the specialists involved, and every member of the Ryegate team: thank you. Your dedication, empathy, and support mean more than words can ever fully express. You have made an immeasurable difference to our lives, and for that, we will always be grateful.

Masterclasses in NF: Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Prof. Dr. Berthold Pemp

OT Sabine Koinig

Masterclasses in NF: Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Assoc. Prof. Dr. Gregor Kasprian

Dr. Hector Salvador, MD

Masterclasses in NF: The Patients’ Perspective: A Masterclass on NF Care Held by NF Patients

Masterclasses in NF: Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

 

Michel Kalamarides MD

Masterclasses in NF: Management Of Plexiform Neurofibromatosis in NF1- Rianne Oosterbrink, Justus L Groen, Karine Lascelles

Masterclasses in NF1: 1.Management Of Plexiform Neurofibromatosis in NF1

Rianne Oosterbrink MD

Justus L Groen MD

Karine Lascelles MD

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK